NeurAxis, Inc. (NRXS) Key Metrics
NRXS valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $96.7M
- Enterprise value
- $83.8M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 18.2 10-yr median 6.8
- Price / book
- 13.6
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 1.36
NRXS key metrics, 2020–2025
Fiscal year ended December 31, 2025 · U.S. dollarsNRXS valuation Price multiples at each fiscal year-end price.
Price / sales+90.9%
11.6
2025 · hover or tap a bar for each year
20202025
Price / book+54.3%
12.1
2025 · hover or tap a bar for each year
20202025
Free cash flow yield+22.0 pts
−15.7%
2025 · hover or tap a bar for each year
20202025
NRXS returns How much profit the business earns on the capital it uses.
Return on equity
−285.4%
2025 · hover or tap a bar for each year
20202025
Return on assets+173.2 pts
−139.8%
2025 · hover or tap a bar for each year
20202025
Free cash flow margin+47.0 pts
−181.1%
2025 · hover or tap a bar for each year
20202025
Asset turnover−37.3%
0.64
2025 · hover or tap a bar for each year
20202025
NRXS per-share figures Results divided by the shares outstanding at year-end.
Revenue per share+1.2%
$0.39
2025 · hover or tap a bar for each year
20202025
Earnings per share
−$0.86
2025 · hover or tap a bar for each year
20202025
Free cash flow per share
−$0.71
2025 · hover or tap a bar for each year
20202025
Book value per share+25.2%
$0.37
2025 · hover or tap a bar for each year
20202025
Shares outstanding+31.3%
9.1M
2025 · hover or tap a bar for each year
20202025
NRXS financial health Debt, liquidity and how easily interest is covered.
Debt / equity−46.5%
0.12
2025 · hover or tap a bar for each year
20202025
Net debt−$1.3M
−$4.5M
2025 · hover or tap a bar for each year
20202025
Current ratio+17.1%
2.05
2025 · hover or tap a bar for each year
20202025
Interest coverage
-105.9
2025 · hover or tap a bar for each year
20202025
Debt / assets−34.6%
0.07
2025 · hover or tap a bar for each year
20202025
NRXS efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding+1 days
23 days
2025 · hover or tap a bar for each year
20202025
Days of inventory+65 days
98 days
2025 · hover or tap a bar for each year
20202025
Days payables outstanding−669 days
239 days
2025 · hover or tap a bar for each year
20202025
Cash conversion cycle+735 days
-118 days
2025 · hover or tap a bar for each year
20202025
Capex / revenue−0.2 pts
0.9%
2025 · hover or tap a bar for each year
20202025
NRXS valuation history
Fiscal year-endToday6-year median
NRXS returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
NRXS debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
NRXS price vs earnings per share
Share price at year-endEPS (right axis)
NRXS key metrics
2020–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| Market capitalization | $41.2M | $16.3M | $16.8M | — | — | — |
| Enterprise value | $36.7M | $13.0M | $17.0M | — | — | — |
| Price / sales | 11.6 | 6.1 | 6.8 | — | — | — |
| Price / book | 12.1 | 7.9 | — | — | — | — |
| EV / sales | 10.3 | 4.9 | 6.9 | — | — | — |
| Earnings yield | −18.9% | −50.7% | −87.0% | — | — | — |
| Free cash flow yield | −15.7% | −37.7% | −40.2% | — | — | — |
| Share price at fiscal year-end | $4.54 | $2.35 | $2.67 | — | — | — |
| Per share | ||||||
| Revenue per share | $0.39 | $0.39 | $0.39 | $0.32 | $0.51 | $0.36 |
| Earnings per share | −$0.86 | −$1.19 | −$2.32 | −$0.57 | −$0.56 | −$0.69 |
| Operating cash flow per share | −$0.71 | −$0.88 | −$1.06 | −$0.27 | −$0.42 | −$0.77 |
| Free cash flow per share | −$0.71 | −$0.89 | −$1.07 | −$0.28 | −$0.42 | −$0.77 |
| Cash per share | $0.55 | $0.53 | $0.01 | $0.03 | $0.06 | $0.35 |
| Book value per share | $0.37 | $0.30 | −$0.22 | −$0.66 | −$0.15 | $0.31 |
| Tangible book value per share | $0.34 | $0.28 | −$0.24 | −$0.67 | −$0.16 | $0.30 |
| Capex per share | $0.00 | $0.00 | $0.01 | $0.01 | $0.00 | $0.01 |
| Debt per share | $0.05 | $0.07 | $0.04 | $0.07 | $0.08 | $0.06 |
| Shares outstanding | 9.1M | 6.9M | 6.3M | 8.4M | 5.4M | 5.4M |
| Change in shares outstanding | +31.3% | +9.9% | −25.2% | +56.3% | 0.0% | — |
| Returns & profitability | ||||||
| Return on equity (ROE) | −285.4% | — | — | — | — | −226.7% |
| Return on assets (ROA) | −139.8% | −312.9% | — | −426.6% | −170.6% | −133.6% |
| Return on tangible assets | −127.3% | −176.8% | — | −340.7% | −411.1% | −134.8% |
| Free cash flow margin | −181.1% | −228.1% | −275.0% | −87.9% | −82.2% | −215.9% |
| Financial health | ||||||
| Total debt | $416,611 | $473,405 | $224,260 | $598,821 | $439,275 | $311,492 |
| Cash & short-term investments | $5.0M | $3.7M | $78,560 | $253,699 | $320,858 | $1.9M |
| Net debt | −$4.5M | −$3.2M | $145,700 | $345,122 | $118,417 | −$1.6M |
| Debt / equity | 0.12 | 0.23 | — | — | — | 0.19 |
| Debt / assets | 0.07 | 0.10 | 0.44 | 0.40 | 0.58 | 0.11 |
| Current ratio | 2.05 | 1.75 | 0.13 | 0.07 | 0.34 | 2.44 |
| Quick ratio | 1.96 | 1.74 | 0.12 | 0.06 | 0.32 | 2.33 |
| Interest coverage | -105.9 | -23.8 | -1.2 | -8.1 | -80.4 | -54.4 |
| Working capital | $2.9M | $1.8M | −$1.6M | −$6.5M | −$933,847 | $1.5M |
| Invested capital | −$1.1M | −$1.2M | −$1.3M | −$5.2M | −$707,243 | $59,744 |
| Tangible asset value | $3.1M | $2.0M | −$1.5M | −$5.7M | −$849,616 | $1.6M |
| Net current asset value | $2.7M | $1.6M | −$1.7M | −$6.6M | −$1.1M | $1.3M |
| Graham net-net per share | $0.25 | $0.18 | −$0.28 | −$0.79 | −$0.22 | $0.19 |
| Capital allocation | ||||||
| Capex / revenue | 0.9% | 1.0% | 2.9% | 2.3% | 0.1% | 1.4% |
| Capex / depreciation | 0.52 | 0.73 | 1.76 | 1.65 | 0.04 | 0.77 |
| Stock-based compensation / revenue | 16.7% | 52.3% | 30.5% | 1.0% | 1.8% | 2.5% |
| R&D / revenue | 13.8% | 7.7% | 6.9% | 8.4% | 7.5% | 8.6% |
| SG&A / revenue | 289.8% | 345.3% | 351.7% | 206.1% | 184.5% | 279.9% |
| Efficiency | ||||||
| Days sales outstanding | 22.5 | 21.6 | 18.4 | 19.7 | 28.6 | 58.9 |
| Days of inventory on hand | 97.7 | 33.0 | 41.7 | 53.6 | 57.0 | 81.1 |
| Days payables outstanding | 238.7 | 908.0 | 1,682.3 | 1,275.3 | 253.0 | 124.8 |
| Cash conversion cycle (days) | -118.5 | -853.4 | -1,622.3 | -1,202.0 | -167.4 | 15.1 |
| Receivables turnover | 16.21 | 16.90 | 19.87 | 18.53 | 12.76 | 6.20 |
| Payables turnover | 1.53 | 0.40 | 0.22 | 0.29 | 1.44 | 2.92 |
| Inventory turnover | 3.73 | 11.05 | 8.75 | 6.80 | 6.41 | 4.50 |
| Asset turnover | 0.64 | 1.02 | 2.47 | 2.40 | 1.53 | 0.69 |
| Average receivables | $220,160 | $158,892 | $123,783 | $144,850 | $213,315 | $311,329 |
| Average payables | $368,156 | $900,582 | $1.4M | $1.0M | $324,174 | $164,558 |
| Average inventory | $150,730 | $32,774 | $34,676 | $43,656 | $73,013 | $106,846 |
| Intangibles / total assets | 4.3% | 2.0% | 21.2% | 5.2% | 3.2% | 0.9% |
Computed from NRXS's annual financial statements (latest annual report filed March 19, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
NRXS valuation and financial ratios
NeurAxis earned a return on equity of −285.4% in fiscal 2025. It ended the year with $0.4 million of debt and $5.0 million in cash and short-term investments, a net cash position of $4.5 million. The share count rose 68.8% from 5.4M to 9.1M over 5 years.
See the NRXS income statement, the NRXS chart for price history, or the NRXS stock overview for the latest quote and news.
NRXS key metrics FAQ
What is NeurAxis's return on equity?
NeurAxis's return on equity (ROE) was −285.4% in fiscal 2025: net income of -$7.8 million on average shareholders' equity of $2.7 million.
How much debt does NeurAxis have?
NeurAxis had total debt of $0.4 million at the end of fiscal 2025, a debt-to-equity ratio of 0.12 and more cash than debt.
What is NeurAxis's free cash flow yield?
NeurAxis generated -$6.5 million of free cash flow in fiscal 2025, a free cash flow yield of −15.7% on its market value at year-end ($41.2 million).
What is NeurAxis's current ratio?
NeurAxis's current ratio was 2.05 at the end of fiscal 2025: current assets were 2.05 times current liabilities.